IOL Chemicals and Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
IOL Chemicals and Pharmaceuticals Limited
Equibles does not estimate personal net worth.
Kushal Kumar Rana has spoken on 3 earnings calls across 1 company, most recently for IOL Chemicals and Pharmaceuticals Limited on November 2, 2026. IOL Chemicals and Pharmaceuticals Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“So, currently, our plans are to convert our existing molecules either into the bulk tablets or into the customized requirement, be it blister packing or something.”
“Due to war, the prices were increased substantially in the month of March itself, but after that, it is stable to some extent, and now the prices are, you can say, not on the overturn from the last one month.”
“The product which you have just mentioned, just as you have named, all our existing products, including ibu, metformin, clopidogrel, and this pano-favorite, they are running almost at 85 to 95 percent capacity utilization.”
IOL Chemicals and Pharmaceuticals Limited
Transcript header (unverified)
IOL Chemicals and Pharmaceuticals Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
IOL Chemicals and Pharmaceuticals Limited
Earnings Call for the Quarter Ended June 30, 2026
IOL Chemicals and Pharmaceuticals Limited
Earnings Call for the Quarter Ended March 31, 2026
IOL Chemicals and Pharmaceuticals Limited